Filing Details

Accession Number:
0001213900-23-041328
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-19 08:30:11
Reporting Period:
2023-05-18
Accepted Time:
2023-05-19 08:30:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1690080 180 Life Sciences Corp. ATNF Pharmaceutical Preparations (2834) 813832378
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834681 Ozan Pamir 3000 El Camino Real, Bldg. 4, Suite 200
Palo Alto CA 94306
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-18 5,162 $1.01 8,983 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $0.9801 to $1.02, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.